643 related articles for article (PubMed ID: 17596718)
21. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
[TBL] [Abstract][Full Text] [Related]
22. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J
Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044
[TBL] [Abstract][Full Text] [Related]
23. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
24. Interface between tauopathies and synucleinopathies: a tale of two proteins.
Galpern WR; Lang AE
Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
[TBL] [Abstract][Full Text] [Related]
25. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Spillantini MG; Van Swieten JC; Goedert M
Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
[TBL] [Abstract][Full Text] [Related]
26. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
27. Frontotemporal dementia--Part II. Differential diagnosis, genetics, molecular pathomechanism and pathology.
Galariotis V; Bódi N; Janka Z; Kálmán J
Ideggyogy Sz; 2005 Jul; 58(7-8):220-4. PubMed ID: 16173270
[TBL] [Abstract][Full Text] [Related]
28. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
29. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila.
Blard O; Feuillette S; Bou J; Chaumette B; Frébourg T; Campion D; Lecourtois M
Hum Mol Genet; 2007 Mar; 16(5):555-66. PubMed ID: 17309878
[TBL] [Abstract][Full Text] [Related]
30. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
[TBL] [Abstract][Full Text] [Related]
31. Pick's complex and FTDP-17.
Kertesz A
Mov Disord; 2003 Sep; 18 Suppl 6():S57-62. PubMed ID: 14502657
[TBL] [Abstract][Full Text] [Related]
32. Tau gene mutations and their effects.
Goedert M
Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
[TBL] [Abstract][Full Text] [Related]
33. Structural and microtubule binding properties of tau mutants of frontotemporal dementias.
Fischer D; Mukrasch MD; von Bergen M; Klos-Witkowska A; Biernat J; Griesinger C; Mandelkow E; Zweckstetter M
Biochemistry; 2007 Mar; 46(10):2574-82. PubMed ID: 17297915
[TBL] [Abstract][Full Text] [Related]
34. Expression of an altered form of tau in Sf9 insect cells results in the assembly of polymers resembling Alzheimer's paired helical filaments.
Gómez-Ramos A; Abad X; López Fanarraga M; Bhat R; Zabala JC; Avila J
Brain Res; 2004 May; 1007(1-2):57-64. PubMed ID: 15064135
[TBL] [Abstract][Full Text] [Related]
35. Involvement of puromycin-sensitive aminopeptidase in proteolysis of tau protein in cultured cells, and attenuated proteolysis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) mutant tau.
Yanagi K; Tanaka T; Kato K; Sadik G; Morihara T; Kudo T; Takeda M
Psychogeriatrics; 2009 Dec; 9(4):157-66. PubMed ID: 20377816
[TBL] [Abstract][Full Text] [Related]
36. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex.
Winton MJ; Joyce S; Zhukareva V; Practico D; Perl DP; Galasko D; Craig U; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 May; 111(5):401-12. PubMed ID: 16609851
[TBL] [Abstract][Full Text] [Related]
37. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
[TBL] [Abstract][Full Text] [Related]
38. Search for a mutation in the tau gene in a Swiss family with frontotemporal dementia.
Savioz A; Kövari E; Anastasiu R; Rossier C; Saini K; Bouras C; Leuba G
Exp Neurol; 2000 Jan; 161(1):330-5. PubMed ID: 10683298
[TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype correlations in FTDP-17: does form follow function?
Forman MS
Exp Neurol; 2004 Jun; 187(2):229-34. PubMed ID: 15144848
[No Abstract] [Full Text] [Related]
40. Partial deletion of the MAPT gene: a novel mechanism of FTDP-17.
Rovelet-Lecrux A; Lecourtois M; Thomas-Anterion C; Le Ber I; Brice A; Frebourg T; Hannequin D; Campion D
Hum Mutat; 2009 Apr; 30(4):E591-602. PubMed ID: 19263483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
